Seqanswers Leaderboard Ad

Collapse

Announcement

Collapse
No announcement yet.
X
 
  • Filter
  • Time
  • Show
Clear All
new posts

  • Using R package to implement Bayesian phase I/II dose-finding design for three outcom

    Dear all,

    I am trying to implement the work done by Suyu Liu, "A Bayesian Phase I/II Trial Design for Immunotherapy", using R, since the code attached with that work takes a lot of time (more than 20 hours, and the code not complete). So that I tried to use trialr package since it used rstan, but this package allowed me to use two outcomes ( toxicity, efficacy ) and the work of Liu used three outcomes (immune response, toxicity, and efficacy).

    I tried to use the R package trialr for two outcomes using the utility for sensitivity analysis written in R code below (table 1 in the article), I want to see if I used the correct utility and to see how to add a third outcome ( immune response ) to the model

    and thanks in advance.

    Here is the work of Liu:



    ````

    ### My code###
    rm(list = ls())
    library(trialr)

    #Utility
    Uti <- array(0,c(2,3,2)) # order: tox, eff, immuno
    Uti[,,1] <- matrix(c(0,0,50,10,80,35),nrow=2)
    Uti[,,2] <- matrix(c(5,0,70,20,100,45),nrow=2)
    N.max= 60 # patients
    outcomes <- '1NNN 2NNT 3NNT 4NNN 5NTN'
    doses = c(.1,.3,.5,.7,.9)


    fit <- stan_efftox(outcomes,
    real_doses =doses,
    efficacy_hurdle = 0.5, toxicity_hurdle = 0.3,
    p_e = 0.1, p_t = 0.1,
    eff0 = 0.5, tox1 = 0.65,
    eff_star = 0.7, tox_star = 0.25,
    alpha_mean = -7.9593, alpha_sd = 3.5487,
    beta_mean = 1.5482, beta_sd = 3.5018,
    gamma_mean = 0.7367, gamma_sd = 2.5423,
    zeta_mean = 3.4181, zeta_sd = 2.4406,
    eta_mean = 0, eta_sd = 0.2,
    psi_mean = 0, psi_sd = 1,
    seed = 123)

    ndoses <- length(fit$prob_tox)
    plot(1:ndoses, fit$prob_tox, type="b", pch=19, xlab="Dose level", ylab="Probability of toxicity", ylim=c(0,max(fit$prob_tox) + 0.15), col="green")
    points(1:ndoses,fit$prob_eff, type="b", pch=18, col="blue")
    abline(h=0.3, lwd=2, lty=4, col = "red")
    legend(1, 0.4, legend=c("Toxicity", "Effecacy"),
    col=c("green", "blue"), lty=1:2, cex=0.8)

    ````

  • #2
    Thank you so much for this information; it’s really a very good information and very authentic and useful information for us. I really appreciate you have share this information.
    If you know more about this information just click here ptcl speed test and check more information with more reasonable and authentic way.

    Comment

    Latest Articles

    Collapse

    • seqadmin
      Best Practices for Single-Cell Sequencing Analysis
      by seqadmin



      While isolating and preparing single cells for sequencing was historically the bottleneck, recent technological advancements have shifted the challenge to data analysis. This highlights the rapidly evolving nature of single-cell sequencing. The inherent complexity of single-cell analysis has intensified with the surge in data volume and the incorporation of diverse and more complex datasets. This article explores the challenges in analysis, examines common pitfalls, offers...
      06-06-2024, 07:15 AM
    • seqadmin
      Latest Developments in Precision Medicine
      by seqadmin



      Technological advances have led to drastic improvements in the field of precision medicine, enabling more personalized approaches to treatment. This article explores four leading groups that are overcoming many of the challenges of genomic profiling and precision medicine through their innovative platforms and technologies.

      Somatic Genomics
      “We have such a tremendous amount of genetic diversity that exists within each of us, and not just between us as individuals,”...
      05-24-2024, 01:16 PM

    ad_right_rmr

    Collapse

    News

    Collapse

    Topics Statistics Last Post
    Started by seqadmin, 06-07-2024, 06:58 AM
    0 responses
    13 views
    0 likes
    Last Post seqadmin  
    Started by seqadmin, 06-06-2024, 08:18 AM
    0 responses
    23 views
    0 likes
    Last Post seqadmin  
    Started by seqadmin, 06-06-2024, 08:04 AM
    0 responses
    20 views
    0 likes
    Last Post seqadmin  
    Started by seqadmin, 06-03-2024, 06:55 AM
    0 responses
    14 views
    0 likes
    Last Post seqadmin  
    Working...
    X